Results 141 to 150 of about 44,743 (233)

MLH1 wt Allele [PDF]

, 2020
openaire   +1 more source

Immunohistochemical Expression of MLH1 and MSH2 in Colorectal Carcinoma and Its Correlation With Clinicopathological Parameters. [PDF]

Cureus
Pragnya C, Patil V.
europepmc   +1 more source

Germline MLH1 c.-42 C > T is a likely pathogenic variant predisposing to a reduced-penetrance/modified Lynch syndrome phenotype featuring MLH1-methylated cancers. [PDF]

Fam Cancer
Buchanan DD, Alvarez R, Mahmood K, Clendenning M, Georgeson P, Walker R, Como J, Preston SG, Joseland S, Mohammadsaeedi K, Aguirre F, Zhou L, Hazelett DJ, Jenkins MA, Rosty C, Winship IM, Macrae FA, Dwarte TM, Nixon D, Hitchins MP, Joo JE.   +20 more
europepmc   +1 more source

MLH1 Gene Promoter Hypermethylation [PDF]

, 2020
openaire   +1 more source

Analysis of DNA mismatch repair and microsatellite instability in molecular typing of endometrial carcinoma. [PDF]

Discov Oncol
Li NM, Cheng HP, Zhou P, Li XH.
europepmc   +1 more source

Moving the needle on colorectal cancer genetics: it takes more than two to TANGO. [PDF]

, 2018
Carvajal-Carmona, Luis G
core  

Deleterious MLH1 Gene Mutation [PDF]

, 2020
openaire   +1 more source

Mismatch repair protein MLH1 suppresses replicative stress in BRCA2-deficient breast tumors

The Journal of Clinical Investigation
Loss of BRCA2 (breast cancer 2) is lethal for normal cells. Yet it remains poorly understood how, in BRCA2 mutation carriers, cells undergoing loss of heterozygosity overcome the lethality and undergo tissue-specific neoplastic transformation.
Satheesh K. Sengodan, Xiaoju Hu, Vaishnavi Peddibhotla, Kuppusamy Balamurugan, Alexander Y. Mitrophanov, Lois McKennett, Suhas S. Kharat, Rahul Sanawar, Vinod Kumar Singh, Mary E. Albaugh, Sandra S. Burkett, Yongmei Zhao, Bao Tran, Tyler Malys, Esta Sterneck, Subhajyoti De, Shyam K. Sharan   +16 more
doaj   +1 more source

Disruption of protein-protein interaction hotspots in the C-terminal domain of MLH1 confers mismatch repair deficiency. [PDF]

NAR Cancer
Fishwick KM, Gomez Vieito D, Greco G, Collotta G, Gatti M, Kulik AA, Guérois R, Corbeski I, Phadte AS, Senoussi I, Cejka P, Pluciennik A, Porro A, Sartori AA.   +13 more
europepmc   +1 more source

Predictive biomarkers of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancer. [PDF]

Ther Adv Med Oncol
Grau Béjar JF, Yaniz Galende E, Genestie C, Blanc-Durand F, Le Formal A, Rouleau É, Leary A.   +6 more
europepmc   +1 more source